STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 59 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $32,000 | -28.9% | 11,763 | -37.4% | 0.00% | – |
| Q3 2019 | $45,000 | -8.2% | 18,794 | +18.9% | 0.00% | – |
| Q2 2019 | $49,000 | -46.7% | 15,808 | -14.1% | 0.00% | -100.0% |
| Q1 2019 | $92,000 | +27.8% | 18,398 | +15.0% | 0.00% | 0.0% |
| Q4 2018 | $72,000 | -21.7% | 15,995 | -16.0% | 0.00% | 0.0% |
| Q3 2018 | $92,000 | -20.0% | 19,049 | -0.4% | 0.00% | 0.0% |
| Q2 2018 | $115,000 | -46.8% | 19,135 | -21.8% | 0.00% | 0.0% |
| Q1 2018 | $216,000 | +30.9% | 24,460 | +7.7% | 0.00% | 0.0% |
| Q4 2017 | $165,000 | – | 22,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,394,994 | $12,948,000 | 44.18% |
| Vivo Capital, LLC | 3,000,000 | $7,200,000 | 2.37% |
| Opaleye Management Inc. | 1,160,000 | $2,784,000 | 1.64% |
| Granite Point Capital Management, L.P. | 606,607 | $1,456,000 | 1.16% |
| Boxer Capital, LLC | 940,000 | $2,256,000 | 0.87% |
| RA Capital Management | 2,279,099 | $5,470,000 | 0.78% |
| Broadfin Capital, LLC | 2,894,581 | $6,947,000 | 0.77% |
| NEA Management Company, LLC | 4,141,308 | $9,939,000 | 0.40% |
| Tredje AP-fonden | 909,581 | $2,183,000 | 0.09% |
| Anson Funds Management LP | 92,219 | $221,000 | 0.07% |